FDA Panel Votes Against PMA for Barricaid Anular Closure
FDA’s Orthopaedic and Rehabilitation Devices Panel recommended against Premarket Approval of Intrinsic Therapeutics’ Barricaid Anular Closure for partial anulus replacement to treat herniated discs. Dec 14, 2017